TheraRadar
← Back
Data updated: Mar 29, 2026

JUBILANT GENERICS

CardiovascularNeurologyGastroenterology
Generics

JUBILANT GENERICS is a generic drug manufacturer focused on Cardiovascular, Neurology, Gastroenterology.

2011
Since
43
Drugs
-
Trials
826
Approved (2yr)

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Cardiovascular 45%
5 drugs
Neurology 45%
5 drugs
Gastroenterology 9%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...